| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Lornoxicam |
| Brand | Xefo® |
| Indication | For the short-term relief of acute mild to moderate pain and symptomatic relief of pain and inflammation in osteoarthritis and symptomatic relief of pain and inflammation in rheumatoid arthritis |
| Assessment Process | |
| Rapid review commissioned | 23/06/2011 |
| Rapid review completed | 07/07/2011 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |
